← Leaderboards
Marisol Betensky
Johns Hopkins University
$586,792
Attributed
$586,792
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $197.2K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$586,792 · 1
By mechanism
K23$586,792 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Michelle M Estrella$9,166,139
- Ayobami T Akenroye$1,708,103
- Jason Eli Farrar$2,896,875
- Christopher B Umbricht$5,202,537
- Donald Small$15,602,119
Others in their field
Other Rising Stars on “Achievement”
- Mari Ostendorf · University Of Washington$51,931,230
- Nancy Jean Sullivan · Boston University Medical Campus$34,500,000
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,500,724
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
- Jaymi L Smith · University Of California-Irvine$10,664,283
Research focus
AchievementAcute Chest SyndromeAdultAffectAfricanAnticoagulantsAnti-Inflammatory AgentsAntithrombin Iii-Protease ComplexAreaArea Under CurveAttentionAwardBiobankBiologicalBiological MarkersBiological Specimen BanksBiomarker DevelopmentBiomarker DiscoveryBiomarker ValidationBlack RaceCareerCareer DevelopmentCase/Control StudiesAccounting
Grant awards (3)
Clinical and Molecular based prognostic factors for Venous Thromboembolism (VTE) in Children with Sickle Cell Disease$192,703
K23 · FY2025 · HL · contact PI
Clinical and Molecular based prognostic factors for Venous Thromboembolism (VTE) in Children with Sickle Cell Disease$196,867
K23 · FY2024 · HL · contact PI
Clinical and Molecular based prognostic factors for Venous Thromboembolism (VTE) in Children with Sickle Cell Disease$197,222
K23 · FY2023 · HL · contact PI